This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Toshiki Mikami, PhD
Postdoctoral Researcher at Novartis
Speaker

Profile

Toshiki Mikami received his bachelor’s and master’s degrees from the University of Tokyo under the supervision of Prof. Kyoko Nozaki, where he began his research in peptide chemistry. In 2020, he joined the group of Prof. Jeffrey Bode at ETH Zurich as a PhD student, working on chemical protein synthesis, site-selective bioconjugation, and protein engineering. Since 2025, he has been a postdoctoral researcher at Novartis, working on peptide synthesis for therapeutic development.

Agenda Sessions

  • Orthogonal Lysine Protecting Groups and a Novel Hydroxylamine for Precision Ubiquitin Chain Synthesis

    11:25